Melissa A. Moss - Publications

Affiliations: 
Biomedical Engineering University of South Carolina, Columbia, SC 
Area:
Biomedical Engineering

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Waugh ML, Wolf LM, Turner JP, Phillips LN, Servoss SL, Moss MA. Modulating the RAGE-Induced Inflammatory Response: Peptoids as RAGE Antagonists. Chembiochem : a European Journal of Chemical Biology. e202300503. PMID 37679300 DOI: 10.1002/cbic.202300503  0.4
2023 Subramanian N, Watson B, Li CZ, Moss M, Liu C. Patterning amyloid-β aggregation under the effect of acetylcholinesterase using a biological nanopore - an study. Sensors and Actuators Reports. 6. PMID 37663321 DOI: 10.1016/j.snr.2023.100170  0.557
2023 Waigi EW, Webb RC, Moss MA, Uline MJ, McCarthy CG, Wenceslau CF. Soluble and insoluble protein aggregates, endoplasmic reticulum stress, and vascular dysfunction in Alzheimer's disease and cardiovascular diseases. Geroscience. PMID 36823398 DOI: 10.1007/s11357-023-00748-y  0.366
2021 Lenhart B, Wei X, Watson B, Wang X, Zhang Z, Li C, Moss M, Liu C. Biosensing of β-Amyloid Peptide Aggregation Dynamics using a Biological Nanopore. Sensors and Actuators. B, Chemical. 338. PMID 33927481 DOI: 10.1016/j.snb.2021.129863  0.465
2021 Gao J, Suo C, Tseng JH, Moss MA, Terry AV, Chapman J. Design and Synthesis of Ranitidine Analogs as Multi-Target Directed Ligands for the Treatment of Alzheimer's Disease. International Journal of Molecular Sciences. 22. PMID 33803769 DOI: 10.3390/ijms22063120  0.702
2019 Bhopatkar AA, Ghag G, Wolf LM, Dean DN, Moss MA, Rangachari V. Cysteine-rich granulin-3 rapidly promotes amyloid-β fibrils in both redox states. The Biochemical Journal. PMID 30782973 DOI: 10.1042/Bcj20180916  0.56
2019 van der Munnik NP, Moss MA, Uline MJ. Obstacles to translating the promise of nanoparticles into viable amyloid disease therapeutics. Physical Biology. PMID 30620933 DOI: 10.1088/1478-3975/Aafc66  0.455
2019 Holt H, Moore E, Riese M, Faucett M, Gonzalez F, Moss M. Binding and Transport of Amyloid-β by P-Glycoprotein: A Novel Therapeutic Target in Alzheimer's Disease Biophysical Journal. 116: 427a-428a. DOI: 10.1016/J.Bpj.2018.11.2300  0.431
2019 Bhopatkar AA, Ghag G, Wolf LM, Dean DN, Moss MA, Rangachari V. Cysteine-Rich Granulin-3 Rapidly Promotes Aggregation of Amyloid-Beta in Both Redox States Biophysical Journal. 116: 351a. DOI: 10.1016/J.Bpj.2018.11.1911  0.512
2018 van der Munnik NP, Sajib MSJ, Moss MA, Wei T, Uline MJ. Determining the Potential of Mean Force for Amyloid-β Dimerization: Combining Self Consistent Field Theory with Molecular Dynamics Simulation. Journal of Chemical Theory and Computation. PMID 29562134 DOI: 10.1021/Acs.Jctc.7B01057  0.51
2018 Wolf LM, Moss MA, Servoss S. Peptoid JPT1A Reduces Rage Expression and Attenuates Inflammatory Response: A Potential AD Therapeutic Biophysical Journal. 114. DOI: 10.1016/J.Bpj.2017.11.2563  0.336
2017 Moore KA, Pate KM, Soto-Ortega DD, Lohse S, van der Munnik N, Lim M, Jackson KS, Lyles VD, Jones L, Glassgow N, Napumecheno VM, Mobley S, Uline MJ, Mahtab R, Murphy CJ, ... Moss MA, et al. Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation. Journal of Biological Engineering. 11: 5. PMID 28191036 DOI: 10.1186/S13036-017-0047-6  0.805
2017 Vance SZ, Redmon X, Hall R, Moore C, Booth G, Hestekin C, Moss M. Understanding the Role of Chain Flexibility in Amyloid Protein Aggregation through Rationally Designed Protein Sequences Biophysical Journal. 112: 52a. DOI: 10.1016/J.Bpj.2016.11.321  0.573
2017 van der Munnik NP, Wei T, Moss MA, Uline MJ. Statistical Thermodynamic Modeling of Early Aβ Oligomer Formation Biophysical Journal. 112: 364a. DOI: 10.1016/J.Bpj.2016.11.1975  0.515
2017 Geiser RJ, Chastain SE, Moss MA. Regulation of Bace1 Mrna Expression in Alzheimer'S Disease by Green Tea Catechins and Black Tea Theaflavins Biophysical Journal. 112. DOI: 10.1016/J.Bpj.2016.11.1965  0.577
2016 Pate KM, Rogers M, Reed JW, van der Munnik N, Vance SZ, Moss MA. Anthoxanthin Polyphenols Attenuate Aβ Oligomer-induced Neuronal Responses Associated with Alzheimer's Disease. Cns Neuroscience & Therapeutics. PMID 27864869 DOI: 10.1111/Cns.12659  0.506
2016 Turner JP, Chastain SE, Park D, Moss MA, Servoss SL. Modulating amyloid-β aggregation: The effects of peptoid side chain placement and chirality. Bioorganic & Medicinal Chemistry. PMID 27776890 DOI: 10.1016/J.Bmc.2016.10.007  0.617
2016 Dean DN, Pate KM, Moss MA, Rangachari V. Conformational Dynamics of Specific Aβ Oligomers Govern Their Ability to Replicate and Induce Neuronal Apoptosis. Biochemistry. PMID 27013020 DOI: 10.1021/Acs.Biochem.6B00161  0.478
2016 Ghag G, Wolf LM, Reed RG, Van Der Munnik NP, Mundoma C, Moss MA, Rangachari V. Fully reduced granulin-B is intrinsically disordered and displays concentration-dependent dynamics. Protein Engineering, Design & Selection : Peds. PMID 26957645 DOI: 10.1093/Protein/Gzw005  0.329
2016 Chastain SE, Moss M. Multi-Trget Therapeutic Potential of Green Tea Catechins and Black Tea Theaflavins Toward Aβ-Induced Signal Pathways Involved in Alzheimer's Disease Biophysical Journal. 110. DOI: 10.1016/J.Bpj.2015.11.2951  0.645
2016 Wang Y, Moss MA. Effect of Resveratrol and Derivatives on Interactions between Alzheimer's Disease Associated Aβ Protein Oligomers and Lipid Membranes: A Quartz Crystal Microbalance Analysis Biophysical Journal. 110: 256a. DOI: 10.1016/J.Bpj.2015.11.1405  0.481
2015 Chakrabarti M, McDonald AJ, Will Reed J, Moss MA, Das BC, Ray SK. Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26682679 DOI: 10.3233/Jad-150450  0.412
2015 Moore K, Wolf LM, Turner JP, Moss MA, Servoss S. The Effect of Peptoids on Aβ Aggregation and NF-κB Activation in Alzheimer's Disease Biophysical Journal. 108: 66. DOI: 10.1016/J.Bpj.2014.11.395  0.586
2015 Dean DN, Kumar A, Pate KM, Moss MA, Rangachari V. Self-Propagative Replication of Amyloid-β Oligomers in Alzheimer Disease Biophysical Journal. 108: 66a. DOI: 10.1016/J.Bpj.2014.11.393  0.585
2015 Pate KM, Rogers M, Moss M. The Ability of Polyphenols to Reduce Aβ-Induced Apoptosis Associated with Alzheimer's Disease Biophysical Journal. 108. DOI: 10.1016/J.Bpj.2014.11.392  0.589
2015 Wang Y, Moss MA. The Resveratrol Derivative Piceatannol Alters the Conformation of Alzheimer's Disease Associated Aβ Protein Aggregates Biophysical Journal. 108: 46a. DOI: 10.1016/J.Bpj.2014.11.283  0.626
2015 Chastain SE, Moss M. Green and Black Tea Polyphenols Mechanistically Inhibit the Aggregation of Amyloid-β in Alzheimer's Disease Biophysical Journal. 108. DOI: 10.1016/J.Bpj.2014.11.1956  0.648
2015 Vance SZ, Pate K, Moore C, Moss M. Phenylethanoids can Modulate Amyloid-β Aggregation Associated with Alzheimer's Disease Biophysical Journal. 108: 219a. DOI: 10.1016/J.Bpj.2014.11.1207  0.648
2014 Kumar A, Pate KM, Moss MA, Dean DN, Rangachari V. Self-propagative replication of Aβ oligomers suggests potential transmissibility in Alzheimer disease. Plos One. 9: e111492. PMID 25365422 DOI: 10.1371/Journal.Pone.0111492  0.589
2014 Pryor NE, Moss MA, Hestekin CN. Capillary electrophoresis for the analysis of the effect of sample preparation on early stages of Aβ1-40 aggregation. Electrophoresis. 35: 1814-20. PMID 24729203 DOI: 10.1002/Elps.201400012  0.597
2014 Turner JP, Lutz-Rechtin T, Moore KA, Rogers L, Bhave O, Moss MA, Servoss SL. Rationally designed peptoids modulate aggregation of amyloid-beta 40. Acs Chemical Neuroscience. 5: 552-8. PMID 24689364 DOI: 10.1021/Cn400221U  0.643
2013 Pate K, Rogers M, Moss MA. Ability of polyphenols to attenuate alzheimer's disease by reducing nuclear factor- ΚB activation through inhibition of both amyloid- Î' oligomer formation and reactive oxygen species Food, Pharmaceutical and Bioengineering Division 2013 - Core Programming Area At the 2013 Aiche Annual Meeting: Global Challenges For Engineering a Sustainable Future. 741.  0.391
2012 Pryor NE, Moss MA, Hestekin CN. Unraveling the early events of amyloid-β protein (Aβ) aggregation: techniques for the determination of Aβ aggregate size. International Journal of Molecular Sciences. 13: 3038-72. PMID 22489141 DOI: 10.3390/Ijms13033038  0.601
2011 Pryor E, Kotarek JA, Moss MA, Hestekin CN. Monitoring insulin aggregation via capillary electrophoresis. International Journal of Molecular Sciences. 12: 9369-88. PMID 22272138 DOI: 10.3390/Ijms12129369  0.763
2011 Soto-Ortega DD, Murphy BP, Gonzalez-Velasquez FJ, Wilson KA, Xie F, Wang Q, Moss MA. Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center. Bioorganic & Medicinal Chemistry. 19: 2596-602. PMID 21458277 DOI: 10.1016/J.Bmc.2011.03.010  0.811
2011 Gonzalez-Velasquez F, Reed JW, Fuseler JW, Matherly EE, Kotarek JA, Soto-Ortega DD, Moss MA. Activation of brain endothelium by soluble aggregates of the amyloid-β protein involves nuclear factor-κB. Current Alzheimer Research. 8: 81-94. PMID 21143156 DOI: 10.2174/156720511794604606  0.748
2010 Kotarek JA, Moss MA. Impact of phospholipid bilayer saturation on amyloid-beta protein aggregation intermediate growth: a quartz crystal microbalance analysis. Analytical Biochemistry. 399: 30-8. PMID 20018160 DOI: 10.1016/J.Ab.2009.12.016  0.836
2010 Gonzalez-Velasquez FJ, Reed JW, Fuseler JW, Matherly EE, Kotarek JA, Soto-Ortega DD, Moss MA. Soluble amyloid-β protein aggregates induce nuclear factor-κB mediated upregulation of adhesion molecule expression to stimulate brain endothelium for monocyte adhesion Journal of Adhesion Science and Technology. 24: 2105-2126. DOI: 10.1163/016942410X507948  0.761
2009 Davis TJ, Soto-Ortega DD, Kotarek JA, Gonzalez-Velasquez FJ, Sivakumar K, Wu L, Wang Q, Moss MA. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight. Molecular Pharmacology. 76: 405-13. PMID 19483107 DOI: 10.1124/Mol.109.055301  0.757
2009 Reyes Barcelo AA, Gonzalez-Velasquez FJ, Moss MA. Soluble aggregates of the amyloid-beta peptide are trapped by serum albumin to enhance amyloid-beta activation of endothelial cells. Journal of Biological Engineering. 3: 5. PMID 19397812 DOI: 10.1186/1754-1611-3-5  0.639
2008 Gonzalez-Velasquez FJ, Kotarek JA, Moss MA. Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers. Journal of Neurochemistry. 107: 466-77. PMID 18702666 DOI: 10.1111/J.1471-4159.2008.05618.X  0.839
2008 Kotarek JA, Johnson KC, Moss MA. Quartz crystal microbalance analysis of growth kinetics for aggregation intermediates of the amyloid-beta protein. Analytical Biochemistry. 378: 15-24. PMID 18396143 DOI: 10.1016/J.Ab.2008.03.022  0.799
2008 Gonzalez-Velasquez FJ, Moss MA. Soluble aggregates of the amyloid-beta protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells. Journal of Neurochemistry. 104: 500-13. PMID 17953673 DOI: 10.1111/J.1471-4159.2007.04988.X  0.622
2008 Gonzalez-Velasquez FJ, Kotarek JA, Moss MA. Activation of endothelium in Alzheimer's disease brain involves soluble aggregates of the amyloid-beta protein Aiche Annual Meeting, Conference Proceedings 0.829
2008 Kotarek JA, Johnson KC, Moss MA. Quartz crystal microbalance analysis of growth kinetics for aggregation intermediates of the amyloid-β protein Aiche Annual Meeting, Conference Proceedings 0.803
2005 Nichols MR, Moss MA, Reed DK, Hoh JH, Rosenberry TL. Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers. Microscopy Research and Technique. 67: 164-74. PMID 16103999 DOI: 10.1002/Jemt.20189  0.63
2005 Nichols MR, Moss MA, Reed DK, Hoh JH, Rosenberry TL. Rapid assembly of amyloid-beta peptide at a liquid/liquid interface produces unstable beta-sheet fibers. Biochemistry. 44: 165-73. PMID 15628857 DOI: 10.1021/Bi048846T  0.586
2005 Nichols MR, Moss MA, Reed DK, Cratic-McDaniel S, Hoh JH, Rosenberry TL. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology. The Journal of Biological Chemistry. 280: 2471-80. PMID 15528204 DOI: 10.1074/Jbc.M410553200  0.624
2005 Moss MA. Identification of inhibitory binding faces of β-amyloid fibril formation Aiche Annual Meeting, Conference Proceedings. 8164.  0.567
2004 Moss MA, Varvel NH, Nichols MR, Reed DK, Rosenberry TL. Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association. Molecular Pharmacology. 66: 592-600. PMID 15322251 DOI: 10.1124/Mol.66.3  0.564
2003 Moss MA, Nichols MR, Reed DK, Hoh JH, Rosenberry TL. The peptide KLVFF-K(6) promotes beta-amyloid(1-40) protofibril growth by association but does not alter protofibril effects on cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Molecular Pharmacology. 64: 1160-8. PMID 14573766 DOI: 10.1124/Mol.64.5.1160  0.491
2002 Nichols MR, Moss MA, Reed DK, Lin WL, Mukhopadhyay R, Hoh JH, Rosenberry TL. Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry. 41: 6115-27. PMID 11994007 DOI: 10.1021/Bi015985R  0.493
Show low-probability matches.